Health equity

CUTTING-EDGE RESEARCH SHAPING CHILDREN'S HEALTH SHOWCASED AT THE PEDIATRIC ACADEMIC SOCIETIES 2024 MEETING

Retrieved on: 
Thursday, April 4, 2024
MB, Research, Seattle Children's, Health, Obesity, Bellevue Hospital, Aga Khan University, Perinatal stroke, Child, Health equity, Intelligence, Physician, Knowledge, Mental health, NYU, Doctor of Philosophy, Poverty, Adolescence, Metro Toronto Convention Centre, CME, Infection, Pediatrics, FAAP, PAS, Bioethics, Nursing

TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.

Key Points: 
  • TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.
  • Research on Neonatology, artificial intelligence, adolescent obesity, mental health, infectious diseases, and other health issues will be featured at the Pediatric Academic Societies (PAS) 2024 Meeting
    This unique meeting represents over 70 pediatric specialties and includes more than 350+ sessions, 687 oral abstracts, and 3,300+ posters on general and specialty pediatric health topics, as well as nine Friday pre-conference programs featuring topics on pediatric bioethics, perinatal stroke, kidney health, and more.
  • Attendees can access sessions, posters, and more through the online program guide and the PAS Meeting mobile app.
  • "This is the premier forum for pediatric researchers and providers to share the latest research on global and public health issues," Judith Shaw, PAS program chair.

Empowering Change: AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship

Retrieved on: 
Wednesday, April 3, 2024
Pharmacist, Health, Doctor of Pharmacy, Health equity, Partnership, Diabetes, Howard University, Knowledge, Regression analysis, Research, Moda Health, Walker, Chronic kidney disease, Geography, Hypertension, Collection, Medicine, Assistant director, Nursing

Sinclair brings a wealth of knowledge and a passion for health care research with a keen interest in addressing health disparities.

Key Points: 
  • Sinclair brings a wealth of knowledge and a passion for health care research with a keen interest in addressing health disparities.
  • The collaboration among AMCP Foundation and intern alumni Carly Rodriguez, PharmD, FAMCP VP & Chief Pharmacy Officer, Moda Health, and Courtney Walker, PharmD, RPh, Medical Account Director – Employers West, Novo Nordisk Inc. represents a critical alliance in health disparities research, focusing on unveiling insights into medication adherence disparities.
  • This strategic partnership exemplifies the synergy essential for impactful research, emphasizing a collective commitment to addressing health disparities.
  • In her unique role, Sinclair is at the forefront of research addressing health disparities related to GLP-1s, medications crucial in diabetes treatment.

CVS Health® expands pharmacy tuition assistance and scholarship programs

Retrieved on: 
Wednesday, April 3, 2024
Health, CVS, Face, Achievement Medal, Doctor of Pharmacy, Health equity, Partnership, Education, Patient, CVS Pharmacy, Pharmacist, Student, CVS Health, AACP, FCCP, Nursing

WOONSOCKET, R.I., April 3, 2024 /PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools nationwide.

Key Points: 
  • Investing in the future of community pharmacy helps ease students' financial barriers and challenges, and promotes a stable and inclusive pharmacy workforce pipeline
    WOONSOCKET, R.I., April 3, 2024 /PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools nationwide.
  • The CVS Health PharmD tuition assistance program is available to all eligible CVS Pharmacy interns and consists of a $20,000 award per year.
  • CVS Pharmacy will continue to advance the practice of pharmacy and provide more opportunities for students to enter this important area of health care."
  • In the fall, the program will be expanded to CVS Pharmacy interns in their final two years of pharmacy education, with $20,000 available for each year while working as an intern for CVS Pharmacy.

DIGITAL DIAGNOSTICS NAMES INDUSTRY VETERAN, KURT BLASENA, AS CHIEF COMMERCIAL OFFICER

Retrieved on: 
Tuesday, April 2, 2024
Diagnosis, Software as a service, Growth, Health equity, Knowledge, Publishing, History, Artificial intelligence, Kingdom, Publication, Creativity, Health, Diabetic retinopathy, Medical device

CORALVILLE, Iowa, April 2, 2024 /PRNewswire/ -- Today, Digital Diagnostics – creator of LumineticsCore™, the FDA De Novo cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy, announces healthcare industry veteran, Kurt Blasena as its Chief Commercial Officer. Blasena joins the executive leadership team in the newly created Chief Commercial Officer role with a commitment to improving health equity and care quality through technology in the medical diagnosis and treatment process that is free of racial and ethnic bias.

Key Points: 
  • CORALVILLE, Iowa, April 2, 2024 /PRNewswire/ -- Today, Digital Diagnostics – creator of LumineticsCore™, the FDA De Novo cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy, announces healthcare industry veteran, Kurt Blasena as its Chief Commercial Officer.
  • Digital Diagnostics announces healthcare industry veteran, Kurt Blasena, as its Chief Commercial Officer.
  • "I'm excited to join Digital Diagnostics at this pivotal time of growth in the healthcare AI industry," said Blasena.
  • Digital Diagnostics has a proven track record in the diabetes market and a strong vision for what is to come in the industry."

White House Misses Another Deadline to Finalize Rule Prohibiting Menthol Cigarettes - Delays Cost Lives, Especially Black Lives

Retrieved on: 
Monday, April 1, 2024
Research, NAACP, Health, Tobacco industry, Conference, Organization, The Washington Post, Health equity, Public, African Americans, Smoker, Policy, Delays, Mayor, Smoking, Congressional Black Caucus, Multimedia, Administration, FDA, Tobacco

WASHINGTON, April 1, 2024 /PRNewswire/ -- It is profoundly disappointing and harmful to public health that the Biden Administration has missed yet another deadline to issue a final FDA rule eliminating menthol cigarettes. The Administration delayed issuing the final rule in December and now has missed the new deadline it set to issue the rule by March 2024.

Key Points: 
  • Make no mistake: Delays cost lives, especially Black lives.
  • Delays allow the tobacco industry to continue its predatory targeting of Black and other communities with menthol cigarettes, resulting in 45,000 Black lives lost to smoking-related diseases every year.
  • If Black lives truly matter, it's time to get rid of menthol cigarettes, the only flavored cigarettes still on the market.
  • Research shows that eliminating menthol cigarettes will save up to 654,000 lives within 40 years, including 255,000 Black lives.

Compassionate Care with Excellence: Urban Health Plan Reaches 50-Year Golden Milestone

Retrieved on: 
Monday, April 1, 2024
Diagnosis, Community, Health, Development, Health equity, UHP, Education, Patient, Mental health, Artificial intelligence, Economic development, Human services, Otitis, Ear, News, Compassion, System, Nurse practitioner, Skin, Heart, HRSA, National Association, Nursing

BRONX, N.Y., April 1, 2024 /PRNewswire/ -- Urban Health Plan (UHP), one of the largest community health center systems in New York State, nationally recognized by the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services, as a leader in quality care, announced its 50-year anniversary today. Founded in 1974 by Dr. Richard Izquierdo, a visionary home grown Bronx physician, the organization is celebrating the significant milestone of devoted care and service to highly diverse, culturally rich, and often underserved communities throughout New York City for half a century.

Key Points: 
  • These include Latino, African American, Afro-Caribbean, South Asian, and West African populations, in addition to other emerging patient groups.
  • "The more we can understand the full picture of health drivers, both clinical and social, we can more effectively provide whole-person care with a human touch."
  • The modern, five-story health center will also bring economic development and environmental health benefits to the community.
  • News and updates about Urban Health Plan and its ongoing pursuit of health equity, plus the schedule of events to honor its 50-year legacy, can be found at www.urbanhealthplan.org .

The Kinetix Group and Pfizer Health Equity Work Recognized by PM360

Retrieved on: 
Friday, March 29, 2024
Inflammation, Health, TKG, Atopic dermatitis, Pfizer, Health equity, Patient, Immunology, Unbranded, Multimedia, Marketing, Pharma, Nursing

NEW YORK, March 29, 2024 /PRNewswire/ -- The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative.

Key Points: 
  • NEW YORK, March 29, 2024 /PRNewswire/ -- The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative.
  • The Pfizer Inflammation and Immunology Strategic Customer Group originally developed the idea to address a gap in equitable patient and provider education resources surrounding atopic dermatitis.
  • "I am proud to be a part of a company like TKG, where there is a genuine commitment to addressing health equity and social determinants of health.
  • The Kinetix Group, a healthcare strategic advisory and marketing agency, is a part of Petauri.

Leading Public Health Advocacy Organization Marks the Anniversary of the Affordable Care Act

Retrieved on: 
Thursday, March 28, 2024
ACA, United States Census Bureau, Health, Organization, Congress, Letter, Trust for America's Health, Health equity, Risk, COVID-19, Conditional sentence, Public, Care Act 2014, Smoker, Patient, Affordable Care Act, Death, Insurance, Health policy, Mortality, Medicare, Multimedia, Legislation, Health insurance

WASHINGTON, March 28, 2024 /PRNewswire/ -- This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and affordable for millions more Americans. Despite efforts to repeal and restrict the ACA, the progress the legislation has made toward health equity and improving public health prevention is significant and lifesaving. It must be preserved.

Key Points: 
  • WASHINGTON, March 28, 2024 /PRNewswire/ -- This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA).
  • Despite efforts to repeal and restrict the ACA, the progress the legislation has made toward health equity and improving public health prevention is significant and lifesaving.
  • Health insurance enrollment has soared in the years since the Affordable Care Act became law.
  • The creation of the Prevention and Public Health Fund (PPHF) has been an important tool for improving health outcomes and reducing health expenditures.

$122.5 Million Healthcare Transformation Grant Launches Center for Better Aging

Retrieved on: 
Thursday, March 28, 2024
Community, LDS Family Services, Relaxation, Health equity, Patient, Stroke, City, Health care, Life expectancy, Chronic condition, Patient safety, IDPH, Ageing, Practitioner, Comprehension, Partnership, Risk, Diabetes, Emergency, American College, Social, Longevity, Knowledge, Hospital, University, CBA, HFS, Health, Public health, Chicago State University, Patient safety organization, Heart, Physician, Accreditation, Nursing

CHICAGO, March 28, 2024 /PRNewswire/ -- A one-of-a-kind healthcare collaborative, the Center for Better Aging (CBA) located at St. Bernard Hospital, opens in July with a health equity mandate to serve the growing 50+ population on Chicago's Greater South Side. 

Key Points: 
  • "A whole-person, collaborative approach will be vital to closing the life expectancy gap in the greater South Side community," said Center for Better Aging Executive Director Estrelitta Harmon .
  • CBA partners will elevate the standard of aging adult care and focus on what matters to each patient."
  • St. Bernard Hospital is the lead partner in securing a $122.5 million grant from the Illinois Department of Healthcare and Family Services to fund the nonprofit CBA under the HFS Healthcare Transformation Collaboratives program.
  • HFS is excited to continue this partnership with the Center for Better Aging, as we work together to reduce disparities, better serve customers and ultimately improve health outcomes in South Side communities."

Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials

Retrieved on: 
Thursday, March 28, 2024
Research, SCRS, Pfizer, Health equity, Partnership, SAN, Site, Physician, Pharmaceutical industry

SAN FRANCISCO, Calif., March 28, 2024 /PRNewswire/ -- Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse demographics.

Key Points: 
  • "As an organization, we have been committed to diversity in clinical trials since day one," said Kyle Burtnett, CEO of Headlands Research.
  • "Our partnership with Pfizer has been a critical component in our continued goal of making clinical research accessible to all."
  • Headlands Research Orlando is the fifth and final site in the organization's partnership with Pfizer, fulfilling a multi-year commitment.
  • A multi-therapeutic site, Headlands Research Orlando was built from the ground up to improve health equity and representativeness in clinical research.